Silverberg JI, Eichenfield LF, Blauvelt A, Irvine AD, et al. Orismilast, a PDE4B/D inhibitor, in moderate-to-severe atopic dermatitis: Efficacy and safety from a multicenter, randomized, placebo-controlled, phase 2b dose-ranging study (ADESOS). Br J Dermatol 2025 Jan 7:ljae507. doi: 10.1093.
PMID: 39847538